PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 29 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

28 October 2025

  1. (diff | hist) 11:58 Certificate of analysis 10,014 ±0 SurmountSurma (talk | contribs) correct the description of how lot identifiers are assigned [rollback]
  2. (diff | hist) 08:04 USP General Chapter 85 5,180 +260 ReportReaderRilla (talk | contribs) rm the claim that the method is stability-indicating without a forced-degradation study [rollback]
  3. (diff | hist) 05:09 STEP trial programme 5,534 ±0 EndpointEnid (talk | contribs) cite the trial publication rather than the sponsor press release [rollback]

27 October 2025

  1. (diff | hist) m b 22:34 Contract development and manufacturing organisation 5,011 ±0 CiteBot (talk | contribs) bot: normalise unit spacing [rollback]
  2. (diff | hist) 07:40 Shanghai ERP Biotechnology 8,349 +381 UnitsUrsula (talk | contribs) rm the discount code added by an anonymous editor [rollback]
  3. (diff | hist) 04:21 Proglucagon 6,709 ±0 Chromatokid (talk | contribs) add the counter-regulatory glucagon point, sourced [rollback]
  4. (diff | hist) 03:16 ChinaPeptides 14,759 +1,168 VerifyFirstVida (talk | contribs) attribute the capability claim to the organisation's own material [rollback]

26 October 2025

  1. (diff | hist) m b 21:59 GL Biochem (Shanghai) 16,271 ±0 CategoryBot (talk | contribs) bot: add supplier category [rollback]
  2. (diff | hist) 19:48 Retatrutide 7,421 ±0 SiteReactionSuz (talk | contribs) consistent en dashes in ranges [rollback]
  3. (diff | hist) 18:49 Flourishglobal Peptide Biotech 12,150 +207 BlankVialBo (talk | contribs) add the minimum order quantity for custom synthesis [rollback]
  4. (diff | hist) 13:22 Receptor bias 4,477 ±0 AmylinAmos (talk | contribs) add the counter-regulatory glucagon point, sourced [rollback]
  5. (diff | hist) m 12:49 Fmoc chemistry 4,618 ±0 FreightFenna (talk | contribs) expand §Characteristic side reactions [rollback]
  6. (diff | hist) m 11:09 Arcuate nucleus 5,251 ±0 SurvodutideSaff (talk | contribs) rm the sentence implying the hormone is a drug [rollback]
  7. (diff | hist) m 09:59 Growth hormone secretagogue 4,613 ±0 StabilityStig (talk | contribs) ce, tighten prose [rollback]
  8. (diff | hist) 02:17 Syringe dead space 9,004 +393 ColdChainCleo (talk | contribs) fix indentation in the source [rollback]
  9. (diff | hist) 00:07 Wuhan Wansheng Biotechnology 15,849 +220 ChainCustodyChad (talk | contribs) expand §Operations and documentation practice [rollback]

25 October 2025

  1. (diff | hist) 17:39 Baseline laboratory panel 4,429 ±0 UnitsUrsula (talk | contribs) correct the analyte name to the recommended nomenclature [rollback]
  2. (diff | hist) m 03:03 Fasting insulin 4,198 ±0 MazdutideMads (talk | contribs) correct the analyte name to the recommended nomenclature [rollback]

24 October 2025

  1. (diff | hist) 20:12 AmbioPharm 4,517 +184 VerifyVesna (talk | contribs) correct the other-designations row — those are trading variants, not subsidiaries [rollback]
  2. (diff | hist) m 18:05 Chinese Peptide Company 15,293 ±0 AnaesthesiaAoife (talk | contribs) label the reception tally as weak, self-selected evidence at this point of use [rollback]
  3. (diff | hist) 17:36 Patent expiry and biosimilars 4,553 ±0 CheckSumChase (talk | contribs) fix indentation in the source [rollback]
  4. (diff | hist) 17:03 Limit of detection 4,865 ±0 Retention_Time_Rae (talk | contribs) split §Principle from §Practical limitations [rollback]
  5. (diff | hist) 14:11 PolyPeptide Group (Hangzhou) 8,087 +201 TierTwoTansy (talk | contribs) add the lead time for catalogue lines, as reported [rollback]
  6. (diff | hist) m b 11:48 Albumin binding half-life extension 6,399 ±0 CategoryBot (talk | contribs) bot: update parent category chain [rollback]
  7. (diff | hist) 07:04 Amino acid analysis 4,943 +320 DiluentDiya (talk | contribs) split overlong sentence [rollback]
  8. (diff | hist) 00:00 Shenzhen Hybio Pharmaceutical 9,295 +1,143 DPP4_Dagmar (talk | contribs) correct the trading name — the short code and the legal name are different things [rollback]

23 October 2025

  1. (diff | hist) m 22:53 Peptide aggregation 5,516 ±0 CapitalisationCaz (talk | contribs) state the mass accuracy in parts per million rather than daltons [rollback]
  2. (diff | hist) 18:00 Peptide synthesis 5,649 ±0 NauseaNoor (talk | contribs) add the collapse-temperature point, sourced [rollback]
  3. (diff | hist) 13:46 Peptide stability table 6,798 +1,110 CPeptidePaddy (talk | contribs) add the reset control description [rollback]
  4. (diff | hist) m 12:31 Survodutide 5,445 ±0 Peptide_Pete (talk | contribs) add the molecular formula to the infobox [rollback]
  5. (diff | hist) m 09:28 Global access disparity 4,391 ±0 ManualOfStyleMo (talk | contribs) rm the advice on how to obtain coverage [rollback]
  6. (diff | hist) m b 06:46 Prescribing information 4,506 ±0 StubSorterBot (talk | contribs) bot: add stub category [rollback]
  7. (diff | hist) m 06:32 Vial 25,466 +442 MassSpecMarv (talk | contribs) rm the shipping recommendation — that is advice, not description [rollback]
  8. (diff | hist) m 04:07 Grey market 4,068 ±0 StyleSheetSybil (talk | contribs) add the cross-link to the temperature-excursion article [rollback]

22 October 2025

  1. (diff | hist) m 23:13 Reconstitution of lyophilised peptides 5,761 ±0 BUD_Bertram (talk | contribs) rm the individualised advice — the article describes, it does not instruct [rollback]
  2. (diff | hist) 23:08 GenScript Peptides 8,003 +728 DrTitration (talk | contribs) state which lines are held in regional stock [rollback]
  3. (diff | hist) m b 23:07 Preparative HPLC purification 4,882 ±0 CiteBot (talk | contribs) bot: normalise temperature formatting [rollback]
  4. (diff | hist) m 20:05 Lyophilisation 28,121 +32 SupplyWatchSuri (talk | contribs) add the figure for the lyophilisation cycle and caption it [rollback]
  5. (diff | hist) 16:51 TRIUMPH trial programme 4,703 ±0 DataTableDunja (talk | contribs) cite the trial publication rather than the sponsor press release [rollback]
  6. (diff | hist) m 14:49 Bacterial endotoxin test 5,317 ±0 UnitAuditUwe (talk | contribs) split §Principle from §Practical limitations [rollback]
  7. (diff | hist) 14:27 Haemoglobin A1c 4,243 ±0 NAION_Noel (talk | contribs) add the sample-stability sentence with its storage condition [rollback]
  8. (diff | hist) m b 11:37 Dose escalation schedule 4,993 ±0 CategoryBot (talk | contribs) bot: add stub category [rollback]
  9. (diff | hist) m 06:28 MOTS-c 4,670 ±0 GHK_Gwendolen (talk | contribs) add the stability data with the storage condition it was measured at [rollback]
  10. (diff | hist) 05:03 SinoPep 11,220 +1,599 ReaderRosalie (talk | contribs) add the minimum order quantity for custom synthesis [rollback]
  11. (diff | hist) 02:13 Solid-phase peptide synthesis 5,359 ±0 CDMO_Caradoc (talk | contribs) add the customs-detention point as a logistics fact, sourced [rollback]
  12. (diff | hist) m 02:10 Third-party testing 7,489 ±0 TallySheetTad (talk | contribs) add the second-opinion point: two services, one lot, is a stronger record [rollback]
  13. (diff | hist) m 00:29 Xi'an Mokemei Biotechnology 12,005 +543 Chromatokid (talk | contribs) expand §Regulatory position and legal status [rollback]

21 October 2025

  1. (diff | hist) 19:10 Medutest 5,018 ±0 LeaderLoic (talk | contribs) add the cost basis, since it shapes who submits [rollback]
  2. (diff | hist) m b 14:39 SURMOUNT trial programme 5,021 ±0 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]
  3. (diff | hist) m 13:59 GLP-1 receptor agonist 11,264 +116 Chromatokid (talk | contribs) de-orphan [rollback]
  4. (diff | hist) m b 08:54 Peptide harm reduction 4,800 ±0 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  5. (diff | hist) 06:30 Amylin receptor agonist 5,245 ±0 Peptide_Pete (talk | contribs) add the structural figure and caption it properly [rollback]
  6. (diff | hist) 02:02 Gastric emptying 5,565 ±0 EmptyingElke (talk | contribs) name the enzyme responsible for the cleavage at the first mention [rollback]

20 October 2025

  1. (diff | hist) m 20:31 Incretin effect 7,358 ±0 SatietySunniva (talk | contribs) the half-life given was for the intact peptide; label it [rollback]
  2. (diff | hist) m 17:50 Temperature excursion 18,143 +491 ITT_Imelda (talk | contribs) rm the shipping recommendation — that is advice, not description [rollback]
  3. (diff | hist) 16:34 Dual incretin agonist 5,851 ±0 UnderfillUna (talk | contribs) serial comma per PP:MOS [rollback]
  4. (diff | hist) 16:30 Zhuhai Kerui Biotechnology 9,552 +916 IncretinIvo (talk | contribs) correct the trading name — the short code and the legal name are different things [rollback]
  5. (diff | hist) 13:34 Timeline of incretin therapeutics 4,460 ±0 ExternalLinksEli (talk | contribs) state which salt form the mass in the infobox refers to [rollback]
  6. (diff | hist) 11:43 Hypoglycaemia 4,473 ±0 ToleranceTove (talk | contribs) expand §In the context of this wiki [rollback]
  7. (diff | hist) 09:58 AmbioPharm 4,333 +925 BetaCellBoyd (talk | contribs) de-orphan [rollback]
  8. (diff | hist) 08:11 Batch number 4,573 ±0 PioneerPerdita (talk | contribs) label the community tally as self-reported at this point of use as well [rollback]
  9. (diff | hist) 00:47 Trial data comparison 7,158 +492 MarginNoteMars (talk | contribs) add the sort control to the stability table [rollback]

19 October 2025

  1. (diff | hist) 23:38 Enteroendocrine L cell 5,083 ±0 EmptyingElke (talk | contribs) expand §GLP-1 synthesis and secretion [rollback]
  2. (diff | hist) 21:26 Research use only 7,990 ±0 StateBoardStace (talk | contribs) rm the claim that the position has changed; no source supports it [rollback]
  3. (diff | hist) 19:21 Sigma-Aldrich (Shanghai) Trading 14,884 +1,392 PurityClaimPia (talk | contribs) add the note that this wiki publishes no score and no league table [rollback]
  4. (diff | hist) 16:54 Shanghai Sigma-Audley New Material Technology 13,973 +798 SourceHunterSile (talk | contribs) add the reception tally with its period and count stated [rollback]
  5. (diff | hist) m 14:06 Contraindications of incretin therapy 4,993 ±0 ForgeryFinder (talk | contribs) consistent en dashes in ranges [rollback]
  6. (diff | hist) 12:40 LEADER trial 4,799 ±0 MelanocortinMil (talk | contribs) sentence case in headings per PP:MOS [rollback]
  7. (diff | hist) 11:02 SUSTAIN trial programme 5,153 ±0 OpenLabelOtto (talk | contribs) de-orphan [rollback]
  8. (diff | hist) 03:50 Trifluoroacetate counterion 5,116 +251 CouplingCillian (talk | contribs) convert the method-comparison paragraph to a table [rollback]

18 October 2025

  1. (diff | hist) 14:22 Syringe dead space 8,611 ±0 LeanMassLars (talk | contribs) correct the label on the second column — that is volume, not mass [rollback]
  2. (diff | hist) 05:20 Qingdao Saber Technology Pharmaceutical 8,921 +1,263 CheckSumChase (talk | contribs) correct the trading name — the short code and the legal name are different things [rollback]
  3. (diff | hist) m b 04:40 Electrospray ionisation 4,323 ±0 ArchiveBot (talk | contribs) bot: repair redlinked category [rollback]
  4. (diff | hist) m 03:28 Underfilling 4,882 +208 PrepHPLC_Pia (talk | contribs) state that the report identifies the sample, not the shipment [rollback]

17 October 2025

  1. (diff | hist) m 21:00 Customs seizure 4,785 +269 SemaglutideSasha (talk | contribs) add the cross-link to the legal-status-by-jurisdiction list [rollback]
  2. (diff | hist) 19:59 Active pharmaceutical ingredient 4,569 ±0 ImportPolicyIggy (talk | contribs) attribute the enforcement statement to the published policy [rollback]
  3. (diff | hist) 19:33 Shanghai Wibson Biotechnology 13,616 +1,089 Chromatokid (talk | contribs) fix hyphenation per PP:MOS [rollback]
  4. (diff | hist) 02:23 Guangzhou JEEP Biotechnology 15,232 +1,157 ReportReaderRilla (talk | contribs) add the see-also to the certificate-of-analysis article [rollback]

16 October 2025

  1. (diff | hist) m b 20:59 Peptide supply chain 8,410 ±0 CategoryBot (talk | contribs) bot: normalise unit spacing [rollback]
  2. (diff | hist) m 16:32 PolyPeptide Group (Hangzhou) 7,886 +728 SecondarySrc_Seb (talk | contribs) add the note that this wiki publishes no score and no league table [rollback]
  3. (diff | hist) m 11:18 Melanotan II 4,649 +275 PuffRemoverPax (talk | contribs) add category for the peptide class [rollback]
  4. (diff | hist) 09:25 Lot traceability 5,317 ±0 EndotoxinEd (talk | contribs) add the cost basis, since it shapes who submits [rollback]
  5. (diff | hist) 05:43 Test report forgery 5,391 ±0 CRP_Cormac (talk | contribs) ce per PP:MOS [rollback]
  6. (diff | hist) 04:36 Lixisenatide 4,195 ±0 GsCouplingGil (talk | contribs) the half-life in the lead was the terminal figure; label it as such [rollback]
  7. (diff | hist) 03:19 Triple agonist 4,269 ±0 CagriCass (talk | contribs) add the structural figure and caption it properly [rollback]

15 October 2025

  1. (diff | hist) 18:51 Karl Fischer titration 9,318 ±0 LabRangeLindy (talk | contribs) add the plate-count expression and define its terms [rollback]
  2. (diff | hist) m 17:09 Missed dose 5,277 ±0 CitationChaser (talk | contribs) give the worked example to two significant figures throughout [rollback]
  3. (diff | hist) 16:54 WuXi TIDES 16,214 ±0 LotTraceLuka (talk | contribs) add the catalogue size and label it self-reported [rollback]
  4. (diff | hist) m b 16:12 GenScript Peptides 7,275 ±0 StubSorterBot (talk | contribs) bot: mark outbound storefront link nofollow [rollback]
  5. (diff | hist) 15:57 Multi-dose vial 21,761 +276 Chromatokid (talk | contribs) the rounding in the table lost a decimal place that matters at low doses [rollback]
  6. (diff | hist) 15:46 Aspiration risk under anaesthesia 4,681 ±0 SiteReactionSuz (talk | contribs) expand §How guidance has developed [rollback]
  7. (diff | hist) m b 12:47 Blind sampling 8,193 ±0 StubSorterBot (talk | contribs) bot: add maintenance category [rollback]
  8. (diff | hist) 12:37 Reconstitution calculator 8,662 +293 MoveRequestMio (talk | contribs) add the source for each stability figure in the table [rollback]
  9. (diff | hist) 11:28 Crude peptide 4,775 ±0 CDMO_Caradoc (talk | contribs) give the vial sizes in millilitres of nominal capacity [rollback]
  10. (diff | hist) 11:04 Shanghai ERP Biotechnology 7,968 +1,208 UnderfillUna (talk | contribs) correct the regional-warehouse list — six sites, not five [rollback]
  11. (diff | hist) 09:26 Talk:Trial data comparison 1,307 +96 SurpassSunniva (talk | contribs) /* Head-to-head filter: is the flag applied consistently? */ reply
  12. (diff | hist) 08:55 Talk:Semaglutide 1,233 +93 MTC_Marisol (talk | contribs) /* Rodent C-cell findings: how should the label contraindication be framed? */ reply
  13. (diff | hist) 08:28 Reverse-phase HPLC 5,499 ±0 DeletionDeb (talk | contribs) clarify that mass spectrometry confirms identity, not purity [rollback]
  14. (diff | hist) 07:17 Satiety signalling 5,593 ±0 SyringeSybille (talk | contribs) add the species in which the knockout work was done [rollback]
  15. (diff | hist) 00:27 USP General Chapter 71 4,657 ±0 OrforglipronOona (talk | contribs) clarify that area percent is not mass percent [rollback]